Corantes naturais de urucum - Emepa

sanguíneos em animais que obtiveram uma elevação com o câncer induzidopor DMBA.4- REFERÊNCIAS BIBLIOGRÁFICASBAAK, J.,S., S.; PATH, F. R. C.; HERMSEN, M.; A.; J.; A., MEIJER, G.;SCHMIDT , J.; JANSSEN, E.; A.; M. Genomics and proteomics in cancer.European journal of Cancer, v.39, p.1199-1215, 2003.COTRAN, R.; S.; KUMER, V.; COLLINS, T. ROBBINS. Patologia Estrutural eFuncional. 6a. ed. Rio de Janeiro: Guanabara Koogan. P. 233-293, 2000.BIRT, D.; F.; HENDRICH, S.; WANG, W. Dietary agents in cancer prevention:flavonoids and isoflavonoids. Pharmacology & Therapeutics, v.90, p.157-177,2001.ALBERTS, B., BRAY, D., LEWIS, J., RAFF, M., ROBERTS, K., WATSON, J.D..Biologia Molecular da Célula, 3 a edição, Porto Alegre, Editora Artes Médicas,1204p, 1997.ARBISIER, J.L. Regulation of angiogenesis and tumorigenesis. Seminars inCancer Biology, v. 14, p. 79-80, 2004.BAILLY, C. Homocamptothecins: potent toposomerase I inhibitors andpromising anticancer drugs. Critical Reviews in Oncology/Hematology, v.45,p.91-108, 2003.BENINI, S. MANARA, M.C., BALDINI, N., CERISANO, V., SERRA, M.,MERCURI, M., LOLLINI, P.L., NANNI, P., PICCI, P., SCOTLANDI, K. Inhibitionof insulin-like growth facto I receptor increases the antitumor activity ofdoxorubicin and vincristine against Ewing´s sarcom cells. Clin Cancer Res, v.7,p. 1790-1797, 2001.BIRT, D.F., HENDRICH, S., WANG, W., Dietary agents in cancer prevention:flavonóides and isoflavonoids. Pharmacology & Therapeutics, v.90, p. 157-177,2001.BOERSMA, B.J., BARNES, S., KIRK, M., WANG, C.C., SMITH, M., KIM, H.,PATEL, R., USMAR, V.M.D. Soy isoflavonóides and cancer – metabolism at thetarget site. Mutation Research, v. 480-481, p. 121-127, 2001.143